Loading…

International variation in the management of infants hospitalized with respiratory syncytial virus

Respiratory syncytial virus (RSV) is a frequent cause of hospitalization among infants. To compare patient management in Europe, the United States, and Australia, we analyzed the charts of 1,563 pediatric patients hospitalized with laboratory-confirmed RSV lower respiratory infections during recent...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pediatrics 1998-03, Vol.157 (3), p.215-220
Main Authors: BEHRENDT, C. E, DECKER, M. D, BURCH, D. J, WATSON, P. H
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c291t-243a9594d9c4a43eeae6be369709bc3c2b0dba9b1556e938196604b33f4d3d2d3
cites
container_end_page 220
container_issue 3
container_start_page 215
container_title European journal of pediatrics
container_volume 157
creator BEHRENDT, C. E
DECKER, M. D
BURCH, D. J
WATSON, P. H
description Respiratory syncytial virus (RSV) is a frequent cause of hospitalization among infants. To compare patient management in Europe, the United States, and Australia, we analyzed the charts of 1,563 pediatric patients hospitalized with laboratory-confirmed RSV lower respiratory infections during recent RSV seasons. Half of patients had been seen initially as outpatients. Median duration of hospitalization was 4 days in Australia, Finland, the United Kingdom, and the United States, and 8 or 9 days in Belgium, France, Germany, Italy, and the Netherlands. In a linear regression model that included clinical findings, underlying conditions, prematurity, and age, the leading variable associated with length of stay was "hospitalization in continental Europe". This geographic factor conferred a 1.8-fold longer stay (95% CI: 1.7-1.9) than hospitalization elsewhere. Utilization of nine supportive therapies for RSV varied widely among hospitals, even within the same country. The individual hospital was strongly associated with the use of every therapy studied, independent of patient characteristics and clinical status. Conclusion Management of RSV patients varies markedly by country and hospital. Multicenter RSV trials that measure length of stay should standardize criteria for "readiness for discharge". It may be appropriate to limit international trials to countries with similar median stays for RSV. Variability within multicenter trials could be further controlled by standardizing the use of other therapies and the diagnosis of complications. [PUBLICATION ABSTRACT]
doi_str_mv 10.1007/s004310050798
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_221946736</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1323621461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c291t-243a9594d9c4a43eeae6be369709bc3c2b0dba9b1556e938196604b33f4d3d2d3</originalsourceid><addsrcrecordid>eNpVkM1LAzEUxIMoWKtH70G8rr58bHZzlKK1UPCi5-VtNmtTttmapMr617u1RfD0huE3A28IuWZwxwCK-wggxahyKHR5QiZMCp4xKNQpmYCQkCmm9Tm5iHENI69ZOSH1wicbPCbXe-zoJwb3q6nzNK0s3aDHd7uxPtG-Hc0WfYp01cetS9i5b9vQL5dWNNjRCZj6MNA4eDMkt69zYRcvyVmLXbRXxzslb0-Pr7PnbPkyX8welpnhmqWMS4E617LRRqIU1qJVtRVKF6BrIwyvoalR1yzPldWiZFopkLUQrWxEwxsxJTeH3m3oP3Y2pmrd78bXulhxzrRUhVAjlB0gE_oYg22rbXAbDEPFoNqvWP1bceRvj6UYDXZtQG9c_AtxVoAqpfgBXU1zGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221946736</pqid></control><display><type>article</type><title>International variation in the management of infants hospitalized with respiratory syncytial virus</title><source>Springer Link</source><creator>BEHRENDT, C. E ; DECKER, M. D ; BURCH, D. J ; WATSON, P. H</creator><creatorcontrib>BEHRENDT, C. E ; DECKER, M. D ; BURCH, D. J ; WATSON, P. H</creatorcontrib><description>Respiratory syncytial virus (RSV) is a frequent cause of hospitalization among infants. To compare patient management in Europe, the United States, and Australia, we analyzed the charts of 1,563 pediatric patients hospitalized with laboratory-confirmed RSV lower respiratory infections during recent RSV seasons. Half of patients had been seen initially as outpatients. Median duration of hospitalization was 4 days in Australia, Finland, the United Kingdom, and the United States, and 8 or 9 days in Belgium, France, Germany, Italy, and the Netherlands. In a linear regression model that included clinical findings, underlying conditions, prematurity, and age, the leading variable associated with length of stay was "hospitalization in continental Europe". This geographic factor conferred a 1.8-fold longer stay (95% CI: 1.7-1.9) than hospitalization elsewhere. Utilization of nine supportive therapies for RSV varied widely among hospitals, even within the same country. The individual hospital was strongly associated with the use of every therapy studied, independent of patient characteristics and clinical status. Conclusion Management of RSV patients varies markedly by country and hospital. Multicenter RSV trials that measure length of stay should standardize criteria for "readiness for discharge". It may be appropriate to limit international trials to countries with similar median stays for RSV. Variability within multicenter trials could be further controlled by standardizing the use of other therapies and the diagnosis of complications. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s004310050798</identifier><identifier>CODEN: EJPEDT</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Biological and medical sciences ; Human viral diseases ; Infectious diseases ; Medical sciences ; Viral diseases ; Viral diseases of the respiratory system and ent viral diseases</subject><ispartof>European journal of pediatrics, 1998-03, Vol.157 (3), p.215-220</ispartof><rights>1998 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c291t-243a9594d9c4a43eeae6be369709bc3c2b0dba9b1556e938196604b33f4d3d2d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2170684$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>BEHRENDT, C. E</creatorcontrib><creatorcontrib>DECKER, M. D</creatorcontrib><creatorcontrib>BURCH, D. J</creatorcontrib><creatorcontrib>WATSON, P. H</creatorcontrib><title>International variation in the management of infants hospitalized with respiratory syncytial virus</title><title>European journal of pediatrics</title><description>Respiratory syncytial virus (RSV) is a frequent cause of hospitalization among infants. To compare patient management in Europe, the United States, and Australia, we analyzed the charts of 1,563 pediatric patients hospitalized with laboratory-confirmed RSV lower respiratory infections during recent RSV seasons. Half of patients had been seen initially as outpatients. Median duration of hospitalization was 4 days in Australia, Finland, the United Kingdom, and the United States, and 8 or 9 days in Belgium, France, Germany, Italy, and the Netherlands. In a linear regression model that included clinical findings, underlying conditions, prematurity, and age, the leading variable associated with length of stay was "hospitalization in continental Europe". This geographic factor conferred a 1.8-fold longer stay (95% CI: 1.7-1.9) than hospitalization elsewhere. Utilization of nine supportive therapies for RSV varied widely among hospitals, even within the same country. The individual hospital was strongly associated with the use of every therapy studied, independent of patient characteristics and clinical status. Conclusion Management of RSV patients varies markedly by country and hospital. Multicenter RSV trials that measure length of stay should standardize criteria for "readiness for discharge". It may be appropriate to limit international trials to countries with similar median stays for RSV. Variability within multicenter trials could be further controlled by standardizing the use of other therapies and the diagnosis of complications. [PUBLICATION ABSTRACT]</description><subject>Biological and medical sciences</subject><subject>Human viral diseases</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Viral diseases</subject><subject>Viral diseases of the respiratory system and ent viral diseases</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LAzEUxIMoWKtH70G8rr58bHZzlKK1UPCi5-VtNmtTttmapMr617u1RfD0huE3A28IuWZwxwCK-wggxahyKHR5QiZMCp4xKNQpmYCQkCmm9Tm5iHENI69ZOSH1wicbPCbXe-zoJwb3q6nzNK0s3aDHd7uxPtG-Hc0WfYp01cetS9i5b9vQL5dWNNjRCZj6MNA4eDMkt69zYRcvyVmLXbRXxzslb0-Pr7PnbPkyX8welpnhmqWMS4E617LRRqIU1qJVtRVKF6BrIwyvoalR1yzPldWiZFopkLUQrWxEwxsxJTeH3m3oP3Y2pmrd78bXulhxzrRUhVAjlB0gE_oYg22rbXAbDEPFoNqvWP1bceRvj6UYDXZtQG9c_AtxVoAqpfgBXU1zGw</recordid><startdate>19980301</startdate><enddate>19980301</enddate><creator>BEHRENDT, C. E</creator><creator>DECKER, M. D</creator><creator>BURCH, D. J</creator><creator>WATSON, P. H</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>19980301</creationdate><title>International variation in the management of infants hospitalized with respiratory syncytial virus</title><author>BEHRENDT, C. E ; DECKER, M. D ; BURCH, D. J ; WATSON, P. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c291t-243a9594d9c4a43eeae6be369709bc3c2b0dba9b1556e938196604b33f4d3d2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Biological and medical sciences</topic><topic>Human viral diseases</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Viral diseases</topic><topic>Viral diseases of the respiratory system and ent viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BEHRENDT, C. E</creatorcontrib><creatorcontrib>DECKER, M. D</creatorcontrib><creatorcontrib>BURCH, D. J</creatorcontrib><creatorcontrib>WATSON, P. H</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>PHMC-Proquest健康医学期刊库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BEHRENDT, C. E</au><au>DECKER, M. D</au><au>BURCH, D. J</au><au>WATSON, P. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>International variation in the management of infants hospitalized with respiratory syncytial virus</atitle><jtitle>European journal of pediatrics</jtitle><date>1998-03-01</date><risdate>1998</risdate><volume>157</volume><issue>3</issue><spage>215</spage><epage>220</epage><pages>215-220</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><coden>EJPEDT</coden><abstract>Respiratory syncytial virus (RSV) is a frequent cause of hospitalization among infants. To compare patient management in Europe, the United States, and Australia, we analyzed the charts of 1,563 pediatric patients hospitalized with laboratory-confirmed RSV lower respiratory infections during recent RSV seasons. Half of patients had been seen initially as outpatients. Median duration of hospitalization was 4 days in Australia, Finland, the United Kingdom, and the United States, and 8 or 9 days in Belgium, France, Germany, Italy, and the Netherlands. In a linear regression model that included clinical findings, underlying conditions, prematurity, and age, the leading variable associated with length of stay was "hospitalization in continental Europe". This geographic factor conferred a 1.8-fold longer stay (95% CI: 1.7-1.9) than hospitalization elsewhere. Utilization of nine supportive therapies for RSV varied widely among hospitals, even within the same country. The individual hospital was strongly associated with the use of every therapy studied, independent of patient characteristics and clinical status. Conclusion Management of RSV patients varies markedly by country and hospital. Multicenter RSV trials that measure length of stay should standardize criteria for "readiness for discharge". It may be appropriate to limit international trials to countries with similar median stays for RSV. Variability within multicenter trials could be further controlled by standardizing the use of other therapies and the diagnosis of complications. [PUBLICATION ABSTRACT]</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><doi>10.1007/s004310050798</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6199
ispartof European journal of pediatrics, 1998-03, Vol.157 (3), p.215-220
issn 0340-6199
1432-1076
language eng
recordid cdi_proquest_journals_221946736
source Springer Link
subjects Biological and medical sciences
Human viral diseases
Infectious diseases
Medical sciences
Viral diseases
Viral diseases of the respiratory system and ent viral diseases
title International variation in the management of infants hospitalized with respiratory syncytial virus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A20%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=International%20variation%20in%20the%20management%20of%20infants%20hospitalized%20with%20respiratory%20syncytial%20virus&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=BEHRENDT,%20C.%20E&rft.date=1998-03-01&rft.volume=157&rft.issue=3&rft.spage=215&rft.epage=220&rft.pages=215-220&rft.issn=0340-6199&rft.eissn=1432-1076&rft.coden=EJPEDT&rft_id=info:doi/10.1007/s004310050798&rft_dat=%3Cproquest_cross%3E1323621461%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c291t-243a9594d9c4a43eeae6be369709bc3c2b0dba9b1556e938196604b33f4d3d2d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221946736&rft_id=info:pmid/&rfr_iscdi=true